Skip to main content

Table 5 The pathological T stage for tumors of included studies

From: Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients

Author (year) miRNA Expression level Clinicopathological details
Pathological/clinical Stagea p-value
 ≤ pT2  ≥ pT3
Bucay (2017) miR-3622a Low 68 22 1.000
High 16 1
Colden (2017) miR-466 Low 40 3 < 0.0001
High 13 22
Du (2017) miR-543 Low 18a 4a < 0.001
High 6a 14a
Fu (2016) miR-132 Low 13 4 1.000
High 31 9
Fu (2016) miR-212 Low 23 3 0.063
High 21 10
Jiang (2016) miR-503 Low 27 14 0.03
High 35 5
Nam (2016) miR-301a Low 189 103 0.2968
High 175 118
Saini (2010) miR-203 Low 9 2  
High 10 1
Wang (2015) miR-573 Low 30a 11a 0.003
High 18a 23a
Wang (2017) miR-802 Low 10 17 0.02
High 30 16
Zhang (2018) miR-410-3p Low 29a 11a 0.003
High 17a 23a
  1. aclinical tumor stage